Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study / J.M. Alvarenga, J.Y.. - In: INTERNATIONAL JOURNAL OF DERMATOLOGY. - ISSN 1365-4632. - (2026). [Epub ahead of print] [10.1111/ijd.70617]

Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study

A.V. Marzano;
2026

Janus kinase inhibitors; advanced systemic therapies; atopic dermatitis; biologic therapies; real‐world evidence; regulatory safety risk factors
Settore MEDS-10/C - Malattie cutanee e veneree
2026
4-ago-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
Int J Dermatology - 2026 - Alvarenga - Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 278.29 kB
Formato Adobe PDF
278.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1266855
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 0
social impact